Literature DB >> 27405818

Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.

Xiaotian Wu1,2, Fahima Nekka3,4, Jun Li2,5.   

Abstract

The model-independent estimation of physiological steady-state volume of distribution ([Formula: see text]), often referred to non-compartmental analysis (NCA), is historically based on the linear compartment model structure with central elimination. However the NCA-based steady-state volume of distribution ([Formula: see text]) cannot be generalized to more complex models. In the current paper, two-compartment models with simultaneous first-order and Michaelis-Menten elimination are considered. In particular, two indistinguishable models [Formula: see text] and [Formula: see text], both having central Michaelis-Menten elimination, while first-order elimination exclusively either from central or peripheral compartment, are studied. The model-based expressions of the steady-state volumes of distribution [Formula: see text] and their relationships to NCA-based [Formula: see text] are derived. The impact of non-linearity and peripheral elimination is explicitly delineated in the formulas. Being concerned with model identifiability and indistinguishability issues, an interval estimate of [Formula: see text] is suggested.

Entities:  

Keywords:  Compartment analysis; Indistinguishability; Non-compartmental analysis; Simultaneous first-order and Michaelis–Menten elimination; Steady-state volume of distribution

Mesh:

Substances:

Year:  2016        PMID: 27405818     DOI: 10.1007/s10928-016-9483-z

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  25 in total

1.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

Review 2.  Population pharmacokinetics of therapeutic monoclonal antibodies.

Authors:  Nathanael L Dirks; Bernd Meibohm
Journal:  Clin Pharmacokinet       Date:  2010-10       Impact factor: 6.447

Review 3.  Volumes of distribution.

Authors:  P L Toutain; A Bousquet-Mélou
Journal:  J Vet Pharmacol Ther       Date:  2004-12       Impact factor: 1.786

Review 4.  On the volume of distribution at steady state and its relationship with two-compartmental models.

Authors:  James W T Yates; Philip A Arundel
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

5.  Investigation of the pharmacokinetics of romiplostim in rodents with a focus on the clearance mechanism.

Authors:  Yow-Ming C Wang; Bethlyn Sloey; Teresa Wong; Prerna Khandelwal; Rebeca Melara; Yu-Nien Sun
Journal:  Pharm Res       Date:  2011-04-08       Impact factor: 4.200

6.  Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

Review 7.  Identifiability and indistinguishability of nonlinear pharmacokinetic models.

Authors:  K R Godfrey; M J Chapman; S Vajda
Journal:  J Pharmacokinet Biopharm       Date:  1994-06

Review 8.  EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Authors:  C Bokemeyer; M S Aapro; A Courdi; J Foubert; H Link; A Osterborg; L Repetto; P Soubeyran
Journal:  Eur J Cancer       Date:  2006-12-19       Impact factor: 9.162

Review 9.  Romiplostim: a novel thrombopoiesis-stimulating agent.

Authors:  Sarah Perreault; Julianna Burzynski
Journal:  Am J Health Syst Pharm       Date:  2009-05-01       Impact factor: 2.637

10.  Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

Authors:  Markus Scholz; Sibylle Schirm; Marcus Wetzler; Christoph Engel; Markus Loeffler
Journal:  Theor Biol Med Model       Date:  2012-07-30       Impact factor: 2.432

View more
  2 in total

1.  Mathematical analysis and drug exposure evaluation of pharmacokinetic models with endogenous production and simultaneous first-order and Michaelis-Menten elimination: the case of single dose.

Authors:  Xiaotian Wu; Fahima Nekka; Jun Li
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-07-09       Impact factor: 2.745

2.  Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis Patients.

Authors:  M A Zuur; S Ghimire; M S Bolhuis; A M A Wessels; R van Altena; W C M de Lange; J G W Kosterink; D J Touw; T S van der Werf; O W Akkerman; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.